Teva Pharmaceutical Industries TEVA
NYSE TEVA
$39.82 +0.94 (+2.42%)
As of: Sep 29, 2026 · 3:59 PM EDT

Teva Pharmaceutical Industries (TEVA) Share-based Compensation (2009 - 2026)

Updated

Teva Pharmaceutical Industries (TEVA) reported Share-based Compensation of $40 million for Q2 2026, up 5.3% from $38 million a year earlier but down 7.0% from the prior quarter.

Analysis

Teva Pharmaceutical Industries (TEVA) Share-based Compensation (2009 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Teva Pharmaceutical Industries' Share-based Compensation came in at $168 million, up 24.4% year-over-year; for FY2025, it was $157 million, up 27.6% from FY2024.

  • Share-based Compensation has a five-year compound annual growth rate of 4.0% (FY2020 to FY2025).
  • By year, Share-based Compensation came in at $123 million in FY2024 (+1.7%), $121 million in FY2023 (-2.4%), $124 million in FY2022 (+4.2%) and $119 million in FY2021 (-7.8%).
  • Five-year quarterly Share-based Compensation spans a low of $24 million in Q1 2022 and a high of $51 million in Q4 2025.
  • Year over year, Share-based Compensation has now increased in each of the last seven quarters, with growth averaging 19.3% over the last eight quarters.
  • The high point for year-over-year Share-based Compensation in five years was Q4 2025 (growth of 50.0%); the low point was Q2 2023 (a decline of 23.1%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $43 million (Q1 2026), $51 million (Q4 2025) and $34 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 458.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 166.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 170.20 Mn
10 Teva Pharmaceutical Industries 45.31 Bn 32.16 Bn 2.15 Bn 40.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 40.00 Mn
Mar 31, 2026 43.00 Mn
Dec 31, 2025 51.00 Mn
Sep 30, 2025 34.00 Mn
Jun 30, 2025 38.00 Mn
Mar 31, 2025 34.00 Mn
Dec 31, 2024 34.00 Mn
Sep 30, 2024 29.00 Mn
Jun 30, 2024 32.00 Mn
Mar 31, 2024 28.00 Mn
Dec 31, 2023 28.00 Mn
Sep 30, 2023 31.00 Mn
Jun 30, 2023 30.00 Mn
Mar 31, 2023 32.00 Mn
Dec 31, 2022 36.00 Mn
Sep 30, 2022 26.00 Mn
Jun 30, 2022 39.00 Mn
Mar 31, 2022 24.00 Mn
Dec 31, 2021 33.00 Mn
Sep 30, 2021 26.00 Mn
API Access

Teva Pharmaceutical Industries Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=TEVA&period=max&api_key=YOUR_API_KEY